It provides relevant mechanistic insights in the regulation of these central processes in MB tumor cells, and it runs against the recently established dogma of STRIPAK-MAP4K4 antagonism by demonstrating a cooperative activity of STRN3 and MAP4K4 towards increased invasiveness via the activation of PKCθ and VASP. The gene discussed is PRRT2; the disease is neoplasm.